✅ Product Benefits

1. Dual‑action glucose control – Combines linagliptin (DPP‑4 inhibitor) to enhance insulin and lower glucagon, plus metformin to reduce hepatic glucose output and improve insulin sensitivity .

2. Convenient fixed-dose regimen – Twice-daily tablet simplifies therapy versus separate pills—taken with meals to reduce GI side effects 

3. Suitable patient profiles – Ideal for individuals not achieving glycemic targets with metformin alone, or with intolerance to higher metformin doses .

4. Tolerability & safety – Generally safe; common side effects include diarrhea and nasopharyngitis; hypoglycemia risk increases if combined with insulin or sulfonylureas 

5. No dose adjustment for mild renal impairment – Safe in patients with mild-to-moderate kidney issues; contraindicated if eGFR <30 mL/min 

6. Easily titratable – Maximum recommended dose is 2.5 mg/1000 mg twice daily; dosing may be adjusted based on tolerance and blood sugar response .

7. Affordable & widely available – Priced around ৳12 per tablet (৳72 per 6‑tablet strip); available in Bangladeshi pharmacies and online platforms